Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database Meeting Abstract


Authors: Margalit, O.; Harmsen, W. S.; Shacham-Shmueli, E.; Petersen, M.; Boursi, B.; Saltz, L. B.; Adams, R.; Maughan, T.; Douillard, J. Y.; Van Cutsem, E.; Hurwitz, H.; Bokemeyer, C.; Tebbutt, N. C.; Kabbinavar, F. F.; De Gramont, A.; Shi, Q.; Lenz, H. J.
Abstract Title: Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 200s
Language: English
ACCESSION: WOS:000487345805117
DOI: 10.1200/JCO.2019.37.15_suppl.3539
PROVIDER: wos
Notes: Meeting Abstract: 3539 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz